1 Copenhagen Trial Unit, Cochranecenteret Rigshospitalet, Rigshospitalet, The Capital Region of Denmark2 unknown
Sepsis is a common and frequently fatal condition. Human recombinant activated protein C (APC) has been introduced to reduce the high risk of death associated with severe sepsis or septic shock. This systematic review is an update of a Cochrane review originally published in 2007.
Cochrane Database of Systematic Reviews, 2012, Vol 12
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review